Daniela Rožková graduated in Molecular Biology at the Faculty of Science, Charles University Prague and gained her PhD in 2009. She started her professional career in the laboratory at the Department of Immunology, 2nd Medical Faculty at Charles University in Prague. Her PhD thesis was focused on dendritic cell, immunotherapy treatments for cancer. She was responsible for the cleanrooms and manufacturing procedure facility as well as dendritic cell treatment preparation for the first patient in the Faculty Hospital Motol in Prague.
In 2011 she joined SOTIO as quality assurance manager responsible for the introduction of the quality management system in the GMP manufacturing facility in Prague. Later, she built the Sotio process development team and since 2016 has been the leader of quality control in addition to leadership of the process development team. She held these roles during multiple phase II studies as well as a phase III trial of dendritic cell therapy. In 2020-2021 she was responsible for the technology transfer of CAR-T cell product analytical methods. She has extensive experience in manufacturing as well as quality control cell therapy procedures, GMP expertise and experience in CMC writing.